High-mobility Group

亚型特异性产品

High-mobility Group产品

  • 所有产品(6)
  • High-mobility Group抑制剂 (2)
  • High-mobility Group抗体 (4)
目录号 产品名 产品描述 文献引用 实验数据
S2302 Glycyrrhizin (NSC 167409) Glycyrrhizin (NSC 167409, Glycyrrhizic Acid)是一种直接的高迁移率族蛋白1(HMGB1)的抑制剂,抑制依赖于HMGB1的炎症分子表达和氧化应激反应。调节p38和p-JNK信号通路,而不影响p-ERK信号通路。同时也能抑制11 beta-hydroxysteroid dehydrogenase
Front Immunol, 2023, 14:1024706
Front Immunol, 2023, 10.3389/fimmu.2023.1024706
J Ethnopharmacol, 2023, 303:115948
A5080 SOX9 Rabbit Recombinant mAb
Development, 2023, 10.1242/dev.201306
EMBO J, 2022, 41(17):e108780
NPJ Regen Med, 2022, 10.1038/s41536-022-00217-8
S2376 Ammonium Glycyrrhizinate Ammonium Glycyrrhizinate (AMGZ, Glycyram, Glycyrrhizin ammonium salt, Glycyrrhizic acid ammonium salt)是来自Licorice root的一种独特产品,具有极高的甜味。Ammonium Glycyrrhizinate 是 HMGB1 的直接抑制剂,具有抗炎、抗肿瘤、抗糖尿病的作用。Ammonium Glycyrrhizinate 可抑制几种不相关的DNA和RNA病毒的生长和细胞病理。Ammonium Glycyrrhizinate 还可抑制 hepatic delta 4-5-reductase11 beta-hydroxysteroid dehydrogenase
Eur J Pharmacol, 2024, 962:176171
Pharmacol Res, 2023, 192:106791
Food Funct, 2022, 10.1039/d2fo02337g
A5154 HMGB2 Rabbit Recombinant mAb
A5052 HMGB1 Rabbit Recombinant mAb
A5054 LEF1 Rabbit Recombinant mAb
S2302 Glycyrrhizin (NSC 167409) Glycyrrhizin (NSC 167409, Glycyrrhizic Acid)是一种直接的高迁移率族蛋白1(HMGB1)的抑制剂,抑制依赖于HMGB1的炎症分子表达和氧化应激反应。调节p38和p-JNK信号通路,而不影响p-ERK信号通路。同时也能抑制11 beta-hydroxysteroid dehydrogenase
Front Immunol, 2023, 14:1024706
Front Immunol, 2023, 10.3389/fimmu.2023.1024706
J Ethnopharmacol, 2023, 303:115948
S2376 Ammonium Glycyrrhizinate Ammonium Glycyrrhizinate (AMGZ, Glycyram, Glycyrrhizin ammonium salt, Glycyrrhizic acid ammonium salt)是来自Licorice root的一种独特产品,具有极高的甜味。Ammonium Glycyrrhizinate 是 HMGB1 的直接抑制剂,具有抗炎、抗肿瘤、抗糖尿病的作用。Ammonium Glycyrrhizinate 可抑制几种不相关的DNA和RNA病毒的生长和细胞病理。Ammonium Glycyrrhizinate 还可抑制 hepatic delta 4-5-reductase11 beta-hydroxysteroid dehydrogenase
Eur J Pharmacol, 2024, 962:176171
Pharmacol Res, 2023, 192:106791
Food Funct, 2022, 10.1039/d2fo02337g
A5080 SOX9 Rabbit Recombinant mAb
Development, 2023, 10.1242/dev.201306
EMBO J, 2022, 41(17):e108780
NPJ Regen Med, 2022, 10.1038/s41536-022-00217-8
A5154 HMGB2 Rabbit Recombinant mAb
A5052 HMGB1 Rabbit Recombinant mAb
A5054 LEF1 Rabbit Recombinant mAb

High-mobility Group抑制剂选择性比较

Tags: High-mobility Group inhibitor|High-mobility Group agonist|High-mobility Group activator|High-mobility Group inducer|High-mobility Group antagonist|High-mobility Group signaling pathway|High-mobility Group assay kit
在线咨询
联系我们